Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients
Year: 2007
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.22811
Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of San Francisco, Memorial Sloan Kettering Cancer Center, Harvard University, University of Michigan, U-M Rogel Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Cedars-Sinai Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2114662812
